Presentations

11:00

Peripheral immune profiles and renal impairment parameters synergistically predict fatal SARS-CoV-2 infection in a kidney transplant cohort

Yu Cui (CN)

Bio Abstract

11:10

Standard-of-Care-Informed Unsupervised Learning and Multi-Biomarker Modeling for Diagnosis of Kidney Transplant Rejection

John Friedewald (US)

Bio Abstract

11:15

Spatial and Temporal Dynamics of REG3A as a Biomarker of Intestinal Allograft Health and Rejection

Douglas Farmer (US)

Bio Abstract

11:20

Comparative Perioperative Kinetics of NGAL and Cystatin C in Predicting Acute Kidney Injury After Liver Transplantation

Saurabh Puri (IN)

Bio Abstract

11:25

Torque teno virus viral load as a biomarker of rejection, opportunistic infection, and infection recovery during the first six months post kidney transplantation

Ramyangshu Chakraborty (GB)

Bio Abstract

11:30

CMV-DNA Level in zero-hour kidney tissue is associated with Risk of post-transplant CMV Infection in D+/R− Living Donor Kidney Transplantation

Takehiro Ohyama (JP)

Bio Abstract

11:35

Multidimensional donor–recipient HLA genetic features in relation to post-liver transplant infection risk

Mingyue Li (CN)

Bio Abstract

11:40

Tackling infectious threats post transplantation dash a retrospective cohort study of opportunistic infections in the first year post renal transplant semicolon determinants of infectious risk and impact of pharmacist-led intervention

Justin Beardsley (AU)

Bio Abstract

11:45

Circ-MAPK4 promotes pyroptosis-associated liver fibrosis by regulating the miR-125a-3p–NLRP3 inflammasome axis

Chao Wang (CN)

Bio Abstract

11:50

Host and pathogen pharmacogenetics in Pneumocystis jirovecii pneumonia after kidney transplantation: a retrospective cohort and case–control study

Dirk Kuypers (BE)

Bio Abstract

11:55

Impact of Cytomegalovirus Infection on IgG Glycosylation in Kidney Transplant Recipients

Marta Crespo Barrio (ES)

Bio Abstract